Illumina unveils first-of-its-kind spatial transcriptomics technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
TD Cowen Reiterates Hold Rating on Illumina (ILMN)
February 19, 2025 12:46 PM ESTTD Cowen analyst Dan Brennan reiterated a Hold rating and $140.00 price target on Illumina (NASDAQ: ILMN).
The analyst comments "ILMN unveiled a new spatial transcriptomics technology (sparse details) enabled directly on ILMN sequencers for unbiased whole-transcriptome profiling. We expect additional... More
